Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...
The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.
Piper Sandler raised the firm’s price target on Solventum (SOLV) to $84 from $75 and keeps a Neutral rating on the shares. The firm notes ...
Wells Fargo raised the firm’s price target on Solventum (SOLV) to $75 from $73 and keeps an Equal Weight rating on the shares. The Q4 beat was ...
What Happened? Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the ...
Prime Video announced a March 25 premiere date and revealed the debut trailer for First to the Finish, made in-partnership ...